Consistent with these studies [48], our results demonstrated that the expressions of both ALDOA gene and protein levels were upregulated in HCC patients and that high ALDOA expression was an independent risk factor for the poor prognosis of HCC, indicating that ALDOA represents a potential marker for pathologic classification and prognostic evaluation in HCC. This evidence concerns the gene ALDOA and hepatocellular carcinoma.